Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
LeMaitre Vascular

LeMaitre Vascular (NASDAQ: LMAT) insider transactions

In the twelve months to 10 November 2026, executives and directors of LeMaitre Vascular reported 11 open-market sales of 279,771 shares ($30.0m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in LeMaitre Vascular shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
1 September 2026Roush John ADirectorOption exercise+3,444$48.607,386Form 4
4 June 2026LeMaitre George WChairman and CEOGift−11,974—1,418,045Form 4
4 June 2026LeMaitre George WChairman and CEOGrant or award+11,974—45,374Form 4
8 May 2026Kamke Trent GSenior V. P., OperationsOpen-market sale−2,928$107.003,749Form 4
8 May 2026LeMaitre George WChairman and CEOOpen-market sale−27,881$108.691,430,019Form 4
7 May 2026Jasinski Lawrence JDirectorOption exercise+1,069$47.196,868Form 4
7 May 2026Jasinski Lawrence JDirectorOption exercise+924$54.657,792Form 4
7 May 2026Jasinski Lawrence JDirectorOption exercise+865$101.128,657Form 4
7 May 2026Jasinski Lawrence JDirectorOpen-market sale−3,943$110.004,714Form 4
7 May 2026Ross Bridget ADirectorOption exercise+3,444$48.607,386Form 4
7 May 2026Ross Bridget ADirectorOption exercise+1,600$47.198,986Form 4
7 May 2026Ross Bridget ADirectorOpen-market sale−5,044$111.103,942Form 4
7 May 2026LeMaitre George WChairman and CEOOpen-market sale−18,600$107.641,457,900Form 4
22 April 2026Pellegrino Joseph P JRDirectorOption exercise+2,941$35.4815,021Form 4
11 March 2026Roberts David BPresident and DirectorOpen-market sale−3,312$107.6814,667Form 4
11 March 2026Kamke Trent GSenior V. P., OperationsOption exercise+2,625$35.489,302Form 4
11 March 2026Kamke Trent GSenior V. P., OperationsOpen-market sale−2,625$108.506,677Form 4
10 March 2026LeBlanc Dorian PaulChief Financial OfficerOption exercise+2—2,400Form 4
10 March 2026LeBlanc Dorian PaulChief Financial OfficerShares withheld for tax−96$109.202,302Form 4
2 March 2026LeMaitre George WChairman and CEOGift−5,000—1,532,430Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the LeMaitre Vascular page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.